Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice
Objective: to evaluate the efficacy and safety of cladribine tablets as a treatment for immune reconstitution of highly active multiple sclerosis (HAMS) in general clinical practice.Patients and methods. 34 patients with HAMS who were followed up at the Moscow Multiple Sclerosis Center in 2018–2021...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-02-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1743 |